PMID- 29951563
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200929
IS  - 2326-3253 (Print)
IS  - 2326-3253 (Electronic)
IS  - 2326-3253 (Linking)
VI  - 5
DP  - 2018
TI  - Infliximab-Induced Aseptic Meningitis in a Patient with Crohn's Disease.
PG  - e48
LID - 10.14309/crj.2018.48 [doi]
LID - e48
AB  - Infliximab is an anti-tumor necrosis factor alpha (TNFalpha) monoclonal antibody that 
      treats moderate-to-severe Crohn's disease. In rare cases, infliximab has been 
      associated with drug-induced aseptic meningitis. We present a 46-year-old woman 
      with migraines and inflammatory Crohn's colitis treated with intravenous 
      infliximab and methotrexate. She developed nuchal rigidity, photophobia, and 
      headache 2 days after each of her infliximab infusions, with symptom resolution 1 
      week post-infusion. Her exam, imaging, and cerebrospinal fluid analysis were 
      consistent with drug-induced aseptic meningitis. She discontinued infliximab and 
      started vedolizumab with continued remission of her Crohn's disease.
FAU - Junga, Zachary
AU  - Junga Z
AD  - Gastroenterology Service, Department of Medicine, Walter Reed National Military 
      Medical Center, Bethesda, MD.
FAU - Theeler, Brett
AU  - Theeler B
AD  - Neurology Service, Department of Medicine, Walter Reed National Military Medical 
      Center, Bethesda, MD.
FAU - Singla, Manish
AU  - Singla M
AD  - Gastroenterology Service, Department of Medicine, Walter Reed National Military 
      Medical Center, Bethesda, MD.
LA  - eng
PT  - Case Reports
DEP - 20180620
PL  - United States
TA  - ACG Case Rep J
JT  - ACG case reports journal
JID - 101638398
PMC - PMC6013687
EDAT- 2018/06/29 06:00
MHDA- 2018/06/29 06:01
PMCR- 2018/06/20
CRDT- 2018/06/29 06:00
PHST- 2018/03/01 00:00 [received]
PHST- 2018/05/02 00:00 [accepted]
PHST- 2018/06/29 06:00 [entrez]
PHST- 2018/06/29 06:00 [pubmed]
PHST- 2018/06/29 06:01 [medline]
PHST- 2018/06/20 00:00 [pmc-release]
AID - crj.2018.48 [pii]
AID - 10.14309/crj.2018.48 [doi]
PST - epublish
SO  - ACG Case Rep J. 2018 Jun 20;5:e48. doi: 10.14309/crj.2018.48. eCollection 2018.